| INTRODUCTION
Asthma, atopic eczema and other allergic conditions are complex disorders associated with a variety of environmental factors. They are amongst some of the most prevalent chronic conditions affecting children in economically developed nations and are becoming increasingly prevalent in developing countries. [1] [2] [3] Allergic asthma is characterized by Th2-type inflammation which results in bronchial hyperresponsiveness, airway obstruction and tissue remodelling 4, 5 .
Effective type-2 immune responses are generated by type-2 helper CD4+ T cells (Th2) as well as type-2 innate effector cells. Na€ ıve T cells differentiate into Th1, Th2, Th17 or inducible Tregs, depending upon the cytokine environment. related genes. 7, 8 In contrast, IL-4 acts via STAT6 to activate the transcription factor GATA3, which is critical for Th2 differentiation. 9 In
Th2 cells, GATA3 inhibits IFN-c expression and activates the expression of the Th2-related cytokines IL-4, IL-5 and IL-13. 9,10 DNA methylation plays a key role in the maintenance of these different Tcell lineages, with gene-specific methylation being well documented within IL-4, IFN-c and GATA3 in the Th cell lineage where these genes are transcriptionally silenced.
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Differences in the immune response are detectable at birth, suggesting that in utero environmental exposures have the capacity to modify the set point of the immune system at birth. 12 The differentiation of T cells plays an important role in preventing foetal rejection during pregnancy, resulting in a skewing to T helper (Th)2 immune responses and suppression of Th1-mediated immunity. This bias against proinflammatory cytokines leaves the newborn susceptible to microbial infection, 13 and therefore, development of optimal regulation of gene expression is required to obtain a balanced post-natal immune response. Immaturity in Th1 as well as Treg activity may increase the risk of an inappropriate persistence of a Th2 allergyprone immune phenotype. 14 Consistent with a Th1/Th2 imbalance being associated with an increased asthma risk, a significant increase in GATA3 expression has been found in the airways of asthmatics compared with those of controls. 15 Several single nucleotide polymorphisms (SNPs) in the GATA3 promoter and exons of GATA3 have been associated with atopic eczema and asthma-related phenotypes including high IgE. 16, 17 There is growing evidence that childhood asthma and atopy together with a number of other chronic diseases may originate at least in part in utero. 18 Epidemiological studies have found associations between prenatal nutritional, allergenic and toxicant exposures and an increased susceptibility to atopic disorders. 19, 20 Early-life environmental exposure may alter disease risk through epigenetic processes, such as DNA methylation, which induce heritable changes in gene expression without a change in gene sequence. 21 For example, maternal exposure to polycyclic aromatic hydrocarbons was associated with the increased methylation of the CpG island of acylcoA synthetase long chain family member 3 (ACDL3) and the development of asthma symptoms in children under 5 years of age. 22 A meta-analysis across 13 cohorts has also reported an association between maternal smoking and newborn blood DNA methylation at over 6000 CpG sites, 23 2 | METHODS
| Southampton Women's Survey
In the Southampton Women's Survey (SWS), Southampton, UK, we studied a prospective cohort of women aged 20-34 years. Women who are not pregnant were recruited; those who subsequently conceived were followed through pregnancy and their offspring through infancy and childhood. 28 The umbilical cord was frozen at birth and stored at À70°C.
Outcome assessments were as follows: research nurses examined the child's skin, looking for evidence of visible atopic eczema at ages 12 months and 6-7 years. Mothers were also asked whether the child had dry skin or an itchy skin condition since birth. Case definition of atopic eczema was based on the UK Working Party diagnostic criteria for the definition of atopic eczema 29 ; we omitted a history of asthma or hay fever as a criterion at 12 months because the children were too young to have developed these disorders in infancy. At 3 and 6-7 years, the research nurses asked the mothers whether a doctor had ever diagnosed "asthma" in their child (Inter- 
| Methylation analysis
The methylation of CpG loci within GATA binding protein 3 (GATA3), interleukin-4 (IL-4), interleukin 4 receptor (IL-4R), signal transducer and activator of transcription 4 (STAT4) and T-box transcription factor (TBET); genes that are known to play key roles in maintaining Th1/Th2 balance were analysed in umbilical cord DNA from SWS participants. Sequencing assays were designed to cover the key regulatory regions within these genes that had been shown previously to be differentially methylated during T-cell differentiation 11, 30 or associated with asthma incidence 25 ( Figures 1A , S1, Table S1 ). Sodium bisulphite pyrosequencing was used to measure DNA methylation in IL-4, IL-4R, STAT4 and TBET but because of the sequence context of the CpGs within GATA3, Seqeunom EpiTYPER MassARRAY analysis was used to analyse the methylation status of GATA3. The location of the regions analysed and sequence of primers used are shown in Table S2 (Pyrosequencing amplicons) and Table S3 (GATA3 Sequenom amplicon), together with the methylation ranges for IL-4, IL-4R, TBET and STAT4 (Table S4 ) and for GATA3 (Table S5 ). The methods used for pyrosequencing and Sequenom analysis are described in the Supplementary
Information. Information on co-methylation of sites is shown using a plot similar to a coMET plot 31 in Fig. S2 .
| Statistical analysis
Statistical analysis was carried out using Stata TM 12 (StataCorp, Texas). Distributions of methylation percentages at CpG sites were investigated (Tables S4, S5 ). CpG sites were excluded from analysis if the median methylation was not ≥5% or if the difference between the 5th and 95th percentiles was ≤10%. All CpG sites fulfilled these criteria. The distributions of methylation measurements for many of the CpGs were skewed, so nonparametric tests were used. Associations between cord CpG methylation and asthma and allergy outcomes (doctor-diagnosed asthma at 3 and 6-7 years, atopic eczema at 6-7 years and atopy at 6-7 years) were investigated.
The difference between the central location (ie median) of each group (allergic/non-allergic) was tested using Mann-Whitney tests, and the results presented as the median ratio (median CpG methylation in allergic group/median CpG methylation in non-allergic group) with the corresponding Mann-Whitney P value. Where the median ratio is less than 1, this indicates a protective effect of higher CpG methylation on the allergic outcome. When CpG sites were significantly associated with asthma and allergy phenotypes, logistic regression was used to derive odds ratios after adjusting for appropriate covariates (child's sex, maternal smoking during pregnancy and a batch effect for methylation analysis). The odds ratio describes the multiplicative change in odds for a 1% increase in methylation, all other variables in the model remaining constant.
An odds ratio of less than 1 indicates a protective effect of higher CpG methylation on the allergic outcome. Where adjusted logistic regressions indicated a significant association between CpG methylation and allergic outcome, an additional analysis was undertaken to determine the influence of outliers on the regression coefficients using Pregibon dbeta measure. 32 P values are presented uncorrected for multiple testing. A P value of <.05 was considered significant.
| Electrophoretic mobility shift assays
To examine transcription factor binding at the CpG sites of interest, we undertook electrophoretic mobility shift assays (see Supplemen- tary Information for Methods). were very similar to the main cohort. Maternal smoking was slightly lower in prevalence in the IL-4R and IL-4, TBET and STAT4 sample sets, as was a doctor diagnosis of asthma at 3 years of age. The prevalences of atopy at 3 years and atopic eczema at 6-7 years were slightly higher in the IL-4R sample set, but these differences were not significant (P = .23, P = .73, P = .43 and P = .41, respectively).
3.2 | Association between umbilical cord DNA methylation at birth and doctor-diagnosed asthma at ages 3 years and 6-7 years
The methylation of 35 CpG loci in the regulatory regions of Th1/ Th2 candidate genes was measured at birth in umbilical cord in relation to doctor-diagnosed asthma at ages 3 and 6-7 years (Table S7 ).
The CpG sites measured in this study were selected as they were located within known regulatory regions which had previously been reported to be important for the expression of the gene during Th1/ Th2 differentiation 11, 30 or in the case of IL-4R, previously associated with asthma incidence 25 ( Fig. S1 and Table S1 ). For all CpGs examined, the presence of SNPs was excluded by direct sequencing. For GATA3, 16 CpGs loci, located 2.5 kb upstream of the proximal promoter, were measured ( Figure 1A ). This region has been shown to be highly conserved amongst species 33 and contains several Notch and GATA3 binding sites which have been shown to be critical for GATA3 induction during Th2 differentiation. 33, 34 We found that higher methylation of umbilical cord GATA3 CpGs À2211/À2209 bp was associated with a decreased risk of asthma at ages 3 years (cases = 31, controls = 500, median ratio 0.74, P = .006) and at 6-7 years (cases = 79, controls = 475, median ratio 0.90, P = .048) ( Table 2 ). As we found significant associations between asthma at 3 and 6-7 years and GATA3 CpGs, we then used logistic regression to allow adjustment for appropriate covariates. Logistic regression with asthma at 3 years of age as the outcome, GATA3 CpGs À2211/À2209 bp as the predictor and adjusting for child's sex, maternal smoking during pregnancy and a batch effect for methylation analysis showed an odds ratio for asthma of 0.940 (95%CI 0.895-0.987, cases = 31, controls = 498, P = .012). Logistic regression with asthma at 6-7 years of age adjusting for the same covariates showed an odds ratio for asthma of 0.976 (95% CI 0.949-1.003, cases = 78, controls = 474 P = .077). There was also an association between higher methylation of IL-4R CpG +28239
( Fig. S1C ) (0.98, cases = 15, controls = 85, P = .029) and a lower incidence of asthma at 6-7 years, although this association was not seen at 3 years (Tables 2, S7) and was lost at 6-7 years of age after adjusting for the covariates listed above.
| Association between DNA methylation at birth and childhood atopic eczema
Higher methylation of GATA3 CpGs À2145/À2143 bp was associated with a higher incidence of atopic eczema at 12 months (median ratio 1.20, cases = 67, controls = 575, P = .05), but this association was attenuated after adjusting for child's sex, maternal smoking during pregnancy and a batch effect for methylation analysis (cases = 67, controls = 573, P = .083). There was no association T A B L E 2 Significant associations between the methylation of specific CpG sites in umbilical cord at birth with doctor-diagnosed asthma at ages 3 and 6-7 years
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showing the promoter region of GATA3 and the location of the CpG sites measured. (B/C) Methylation of GATA3 CpGs À2211/À2209 in umbilical cord at birth is associated with doctor-diagnosed asthma incidence at 3 (B) and 6-7 (C) years of age. Methylation has been divided into 4 equal groups according to rank; means and standard error of the means are plotted for each group
between the methylation of these CpGs and atopic eczema at 6-7 years of age (Tables 3, S8 ). An association was observed between the methylation of IL-4R CpG +28239 and atopic eczema at age 12 months (median ratio 1.02, cases = 13, controls = 87, P = .028), and there were borderline associations with methylation of IL-4R
CpG +28269 bp (1.03, cases = 13, controls = 81, P = .059) and STAT4 CpG À229 ( 
| Association between DNA methylation at birth and atopy at 6-7 years
Higher methylation of TBET CpG À18424 (Fig. S1D) , which is located within the upstream enhancer of TBET, 35 was associated with a decreased risk of atopy at 6-7 years (0.98, cases = 37, controls = 104, P = .017) ( Tables 4, S9 ). Logistic regression with atopy at 6-7 years as the outcome, TBET CpG À18424 as the predictor and adjusting for child's sex, maternal smoking during pregnancy and a batch effect for methylation analysis showed an odds ratio for atopy of 0.883 (95% CI 0.781-0.997, cases = 35, controls = 103, P = .045). Methylation at the other CpG sites measured was not associated with atopy at 6-7 years of age.
| Functional significance of altered GATA3

CpG3 and 4 methylation
To determine the functional consequences of CpG À2211 and À2209 methylation within the GATA3 promoter, we examined transcription factor binding to the promoter region of GATA3 using electrophoretic mobility shift assays on nuclear extracts from the human T-cell line Jurkat. We found one specific protein complex bound to a labelled oligonucleotide containing CpGs À2211/À2209.
Binding to this probe was competed out by the addition of an excess of unlabelled specific competitor but not with an excess of a non-specific competitor ( Figure 2A ). Addition of an unlabelled oligonucleotide containing methylated cytosines at CpG À2211/ À2209 also failed to compete out binding to the labelled probe (Figure 2A) , suggesting that CpG À2211/À2209 methylation blocks transcription factor binding to this region of GATA3.
As CpGs À2211/À2209 lie within a putative NF-jB site in the GATA3 promoter, we investigated whether binding to this region could be competed out by the addition of an excess of unlabelled oligonucleotide containing the NF-jB binding consensus binding site.
We found that the addition of an excess of an unlabelled oligonucleotide containing the NF-jB consensus binding sequence very effectively competed out binding ( Figure 2B ), supporting the proposition that NF-jB binds to this region of the GATA3 promoter.
| DISCUSSION
We report that the methylation of specific CpG loci associated with genes involved in Th1/Th2 balance at birth was associated with a later risk of allergic disease. Specifically, we found that higher methylation of CpGs À2211/À2209 located upstream of the transcription start site of the GATA3 gene in umbilical cord tissue at birth was associated with a lower incidence of asthma in childhood.
GATA3, which is a member of the GATA family of zinc-finger transcription factors, plays a critical role in Th1/Th2 balance, as it is required for Th2 cell differentiation, maintenance and cytokine production. 30 The regulation of GATA3 expression is crucial during development, as overexpression of GATA3 can disrupt Th1/Th2 balance. Naive Th cells express a low level of GATA3, and levels of GATA3 then increase during Th2 differentiation but are downregulated during Th1 differentiation. 30 Transgenic mice overexpressing GATA3 in thymocytes and T cells develop thymic lymphomas and spontaneous formation of committed Th2 cells 36, 37 while ectopic expression in developing Th1 cells interferes with the methyl-CpG T A B L E 3 Significant associations found between the methylation of specific CpG sites in umbilical cord at birth with atopic eczema at 12 months of age T A B L E 4 Significant associations were found between the methylation of specific CpG sites in umbilical cord at birth with atopy at 6-7 years of age
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chr17:43147185+ 0.98 (37/104) 0.017* *denotes P < .05. Bold type indicates effect sizes for P values < .05 binding domain protein-2 and promotes histone hyperacetylation on the IL-4 locus. 38 Moreover, mice overexpressing GATA3 develop exacerbated allergen-induced airway inflammation and airway remodelling. 39, 40 Elevated expression of GATA3 is also found in the airways of individuals with asthma, and single nucleotide polymorphisms within GATA3 are associated with an increased incidence of asthma and other allergic phenotypes. 16, 17 GATA3 transcription is regulated by IL-4, STAT6, Notch and itself during T-cell differentiation, 34, [41] [42] [43] although GATA3 has also been shown to be regulated by a variety of other factors including USF, ZEB, E2A, HEB and NF-jB. 44, 45 Interestingly, the GATA3 CpGs À2211/À2209, the sites most strongly associated with later asthma in our data lie within a putative NF-jB binding The association between GATA CpG methylation at À2211/ À2209 and asthma at 3 years of age remained after adjustment for maternal smoking, batch effect for methylation analysis and child's sex, while the association at 6-7 years weakened slightly after adjustment for these variables. Our analyses also found an association between the methylation of specific CpGs within IL-4R in cord tissue at birth and the incidence of atopic eczema in later childhood.
Methylation of IL-4R CpG +28180 was previously reported by SotoRam ırez et al 25 to be positively associated with asthma incidence in the peripheral blood of 18-year-old adolescents. However, in our study, there was no association between CpG+28180 and asthma incidence found; instead, we found a positive association between umbilical cord IL-4R CpG +28269 methylation, the neighbouring CpG site and incidence of atopic eczema at 12 months. Such differences between the two studies may reflect tissue-specific differences in DNA methylation, as we studied methylation in umbilical cord as opposed to in peripheral blood, or differing predominant "asthma" phenotypes in children which we studied, compared to the adolescents in the previous study. Likewise, differences have been seen between early-and late-onset atopic dermatitis; in an Asian mother-offspring cohort, GUSTO (Growing Up in Singapore Towards healthy Outcomes) early-onset atopic dermatitis was found to be mainly associated with familial factors, while late-onset atopic dermatitis was associated with consumption of antibiotics or probiotics. 46 We also identified an association between TBET CpG methylation and atopy at 6-7 years of age, which remained significant after adjustment for confounders. Further studies will be required to determine the robustness of such associations; nonetheless, but our study suggests that the early-life environment may modulate the methylation of key Th1/Th2 genes affecting the later risk of asthma, atopic dermatitis and atopy.
The strengths of the study include the relatively large sample size for GATA3 CpG methylation and prospective collection of data.
Moreover, atopic eczema was ascertained by a standardized algorithm incorporating history and examination, while atopy was assessed objectively by skin prick testing. We also report an association between the methylation of CpG sites within the promoter A third limitation was that we measured the methylation of 35
CpG sites/groups, raising the likelihood that some of the weaker associations identified could represent chance findings. Although the associations between GATA3 CpG À2211/À2209 and childhood asthma do not survive a strict Bonferroni or 5% FDR correction, it is unlikely that these results are false positives. The CpG sites were chosen using a prior hypothesis that Th2 lineage determination genes were likely to be associated with allergic outcomes. In addition, some of the CpG sites are highly correlated as illustrated by the coMET plot 31 in Fig. S2 . The allergic outcomes are also significantly associated with each other (P<.0001) for outcomes at 6-7 years of age, and Bonferroni relies on the assumption that each of the tests is independent. 49 However, the main purpose of a Bonferroni correction is to guard against false positives, and in this study, we sought to functionally validate the association between GATA3 methylation and asthma by examining the significance of altered methylation of the CpG sites associated with asthma risk in human T cells. Our finding that methylation at these CpGs blocked the binding of the transcription factor NF-jB to the promoter region of GATA3 points away from the association of GATA3 methylation with asthma being a false-positive finding.
A further limitation inherent in the Sequenom technique, which we used to measure the methylation of CpGs within GATA3, is that it cannot distinguish some closely neighbouring CpG sites with the mass, hence their reporting as groups (such as CpG À2211/À2209), but because of the sequence content of this region, designing amplicons to use on the pyrosequencer was not feasible. Finally, we did not have information on serum IgE concentrations or on rigorously diagnosed food allergy.
| CONCLUSION S
In conclusion, we have demonstrated that higher methylation of GATA3 CpGs À2211/À2209 at birth was associated with a reduced risk of asthma at ages 3 and 6-7 years. The associations identified by our study provide further evidence of a developmental contribution to later risk of allergic disorders and may in time lead to new biomarkers aiding the diagnosis and treatment of infants at risk of developing these chronic and potentially debilitating diseases.
